{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:44:14Z","timestamp":1791474254691,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010688","name":"Horizon 2020 European Innovation Council Fast Track to Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.euroneuro.2021.04.021","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T01:14:34Z","timestamp":1621559674000},"page":"7-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Bidirectional associations between treatment-resistant depression and general medical conditions"],"prefix":"10.1016","volume":"51","author":[{"given":"Kathrine Bang","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie C.","family":"Momen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte Vogdrup","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleguer","family":"Plana-Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartholomeus C.M.","family":"Haarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmo","family":"Drexhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preben Bo","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Munk-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.euroneuro.2021.04.021_bib0001","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.euroneuro.2012.09.002","article-title":"Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder","volume":"23","author":"Amital","year":"2013","journal-title":"Eur. Neuropsychopharmacol.\u00a0: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0002","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","article-title":"Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD Patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium","volume":"10","author":"Arteaga-Henr\u00edquez","year":"2019","journal-title":"Front Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2021.04.021_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115209","article-title":"Decreased serum level of MiR-146a as sign of chronic inflammation in Type 2 diabetic patients","volume":"9","author":"Balde\u00f3n","year":"2014","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.04.021_bib0005","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.4088\/JCP.16m11310","article-title":"Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder","volume":"78","author":"Benedetti","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.021_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.04.021_bib0007","first-page":"438","article-title":"Treatment and outcome in secondary depression: a naturalistic study of 1087 patients","volume":"48","author":"Black","year":"1987","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.021_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/WCO.0000000000000687","article-title":"Advance in genetics of migraine","volume":"32","author":"de Boer","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2019.09.082","article-title":"Switching antidepressants in the treatment of major depression: when, how and what to switch to?","volume":"261","author":"Boyce","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.021_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(91)90102-U","article-title":"Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults","volume":"37","author":"Breslau","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0011","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3389\/fphys.2018.01834","article-title":"Effect of estrogen on musculoskeletal performance and injury risk","volume":"9","author":"Chidi-Ogbolu","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.021_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.021_bib0013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-0327(85)90057-6","article-title":"Short-term prognosis in primary and secondary major depression","volume":"9","author":"Coryell","year":"1985","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.04.021_bib0014","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.genhosppsych.2007.06.002","article-title":"Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability","volume":"29","author":"Egede","year":"2007","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0015","doi-asserted-by":"crossref","unstructured":"Fagiolini, A. and D.J. Kupfer. 2003. \u201cIs treatment-resistant depression a unique subtype of depression\u00a0?\u201d 3223(03).","DOI":"10.1016\/S0006-3223(02)01670-0"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0016","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psychres.2017.03.006","article-title":"Epidemiology of pharmaceutically treated depression and treatment resistant depression in Taiwan","volume":"252","author":"Fife","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0017","article-title":"Defining treatment-resistant depression","author":"Gaynes","year":"2019","journal-title":"Depress Anxiety"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.021_bib0018","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11481-013-9462-8","article-title":"Evidence for a dysregulated immune system in the etiology of psychiatric disorders","volume":"8","author":"Gibney","year":"2013","journal-title":"J. Neuroimmune Pharmacol.: Off. J.e Soc. NeuroImmune Pharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.021_bib0019","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11845","article-title":"Incidence of, risk factors for, and changes over time in treatment-resistant depression in Denmark: a register-based cohort study","volume":"79","author":"Gronemann","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jad.2021.03.029","article-title":"\u201cTreatment patterns in patients with treatment-resistant depression in danish patients with major depressive disorder","volume":"287","author":"Gronemann","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.021_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236434","article-title":"A register-based approach to identifying treatment-resistant depression-comparison with clinical definitions","volume":"15","author":"H\u00e4gg","year":"2020","journal-title":"PLoS One"},{"issue":"7 Suppl","key":"10.1016\/j.euroneuro.2021.04.021_bib0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.021_bib0023","first-page":"8","article-title":"Major depression comorbid with medical conditions: analysis of quality of life, functioning, and depressive symptom severity","volume":"48","author":"IsHak","year":"2018","journal-title":"Psychopharmacol. Bull."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.021_bib0024","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1176\/ajp.148.3.345","article-title":"12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression)","volume":"148","author":"Keitner","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2021.04.021_bib0025","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwt188","article-title":"Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States","volume":"178","author":"Keyes","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"7 Suppl","key":"10.1016\/j.euroneuro.2021.04.021_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.04.021_bib0027","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1525-1497.2006.00586.x","article-title":"Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes","volume":"21","author":"Kronish","year":"2006","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.021_bib0028","doi-asserted-by":"crossref","first-page":"e76882","DOI":"10.1371\/journal.pone.0076882","article-title":"Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database","volume":"8","author":"Kubitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2020.3219","article-title":"What is the association between depression and cardiovascular disease?","author":"Li","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12991-019-0248-0","article-title":"All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population","volume":"18","author":"Li","year":"2019","journal-title":"Ann. Gen. Psychiatry"},{"issue":"7 Suppl","key":"10.1016\/j.euroneuro.2021.04.021_bib0031","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0004","article-title":"Early labor force exits in patients with treatment-resistant depression: an assessment of work years lost in a danish nationwide register-based cohort study","volume":"10","author":"Madsen","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"Pt A","key":"10.1016\/j.euroneuro.2021.04.021_bib0032","first-page":"250","article-title":"Cause-specific life years lost in individuals with treatment-resistant depression: a danish nationwide register-based cohort study","volume":"280","author":"Madsen","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.021_bib0033","first-page":"7","article-title":"Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways","volume":"32","author":"Maes","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"issue":"10161","key":"10.1016\/j.euroneuro.2021.04.021_bib0034","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"\u201cDepression.\u201d","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet (Lond., Engl.)"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.021_bib0035","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of increased treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary sj\u00f6gren\u2019s syndrome","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fpsyt.2019.00101","article-title":"Is the HPA axis as target for depression outdated, or is there a new hope?","volume":"10","author":"Menke","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0037","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.psych.60.110707.163551","article-title":"Health psychology: developing biologically plausible models linking the social world and physical health","volume":"60","author":"Miller","year":"2009","journal-title":"Annu. Rev. Psychol."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.021_bib0038","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jnnp-2015-312233","article-title":"Migraine and its psychiatric comorbidities","volume":"87","author":"Minen","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"18","key":"10.1016\/j.euroneuro.2021.04.021_bib0039","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa1915784","article-title":"Association between mental disorders and subsequent medical conditions","volume":"382","author":"Momen","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7 Suppl","key":"10.1016\/j.euroneuro.2021.04.021_bib0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish psychiatric central research register","volume":"39","author":"Mors","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"9590","key":"10.1016\/j.euroneuro.2021.04.021_bib0041","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the world health surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.euroneuro.2021.04.021_bib0042","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/acps.13028","article-title":"Incidence of medically treated depression in Denmark among individuals 15-44 years old: a comprehensive overview based on population registers","volume":"139","author":"Musliner","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.021_bib0043","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpsychores.2014.11.018","article-title":"Anxiety and depressive symptoms and medical illness among adults with anxiety disorders","volume":"78","author":"Niles","year":"2015","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.021_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-2982.2005.00974.x","article-title":"Migraine with and without Aura: association with depression and anxiety disorder in a population-based study. The HUNT study","volume":"26","author":"Oedegaard","year":"2006","journal-title":"Cephalalgia\u00a0: Int. J. Headache"},{"issue":"5","key":"10.1016\/j.euroneuro.2021.04.021_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1532-5415.2002.50206.x","article-title":"Association between medical comorbidity and treatment outcomes in late-life depression","volume":"50","author":"Oslin","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0046","article-title":"HPA axis regulation and epigenetic programming of immune-related genes in chronically stressed and non-stressed mid-life women","author":"Palma-Gudiel","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.021_bib0047","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000070584","article-title":"Serum cholesterol in treatment-resistant depression","volume":"47","author":"Papakostas","year":"2003","journal-title":"Neuropsychobiology"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2021.04.021_bib0048","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-0327(00)00186-5","article-title":"Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2","volume":"63","author":"Patten","year":"2001","journal-title":"J. Affect. Disord."},{"issue":"7 Suppl","key":"10.1016\/j.euroneuro.2021.04.021_bib0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"5","key":"10.1016\/j.euroneuro.2021.04.021_bib0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","article-title":"A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders","volume":"71","author":"Pedersen","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.021_bib0051","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/appi.psy.45.3.224","article-title":"Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression","volume":"45","author":"Perlis","year":"2004","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.021_bib0052","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwv324","article-title":"The association between perceived stress and mortality among people with multimorbidity: a prospective population-based cohort study","volume":"184","author":"Prior","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0053","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jad.2018.06.030","article-title":"Mortality in treatment-resistant unipolar depression: a register-based cohort study in Sweden","volume":"238","author":"Reutfors","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.euroneuro.2021.04.021_bib0054","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archpsyc.65.8.870","article-title":"Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features","volume":"65","author":"Rush","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.021_bib0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jamapsychiatry.2015.2688","article-title":"Association of mental disorders with subsequent chronic physical conditions: world mental health surveys from 17 countries","volume":"73","author":"Scott","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.021_bib0056","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1176\/appi.psy.43.4.310","article-title":"Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder","volume":"43","author":"Sonawalla","year":"2002","journal-title":"Psychosomatics"},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0057","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2021.03.005","article-title":"Registry-based studies: what they can tell us, and what they cannot","volume":"45","author":"Taipale","year":"2021","journal-title":"Eur. Neuropsychopharmacol.\u00a0: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.021_bib0058","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1186\/1756-0500-7-796","article-title":"From prescriptions to drug use periods - things to notice","volume":"7","author":"Tanskanen","year":"2014","journal-title":"BMC Res. Notes"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.021_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165196","article-title":"Chronology of onset of mental disorders and physical diseases in mental-physical comorbidity - a national representative survey of adolescents","volume":"11","author":"Tegethoff","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.021_bib0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuroscience.2008.12.058","article-title":"Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus","volume":"159","author":"Weiser","year":"2009","journal-title":"Neuroscience"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:59:59Z","timestamp":1760378399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21002194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":60,"alternative-id":["S0924977X21002194"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.021","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional associations between treatment-resistant depression and general medical conditions","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}